REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

05/03/2020 11:50

RNS Number : 1431F
  
Morgan Stanley Capital Services LLC
  
05 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   04 MARCH 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  11,751


 91.7500 USD


 89.0000 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  34,515


 91.8100 USD


 89.0000 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 128


 89.1700 USD




 CFD


 LONG


 3,404


 89.6436 USD




 CFD


 LONG


 200


 89.8650 USD




 CFD


 LONG


 500


 90.4896 USD




 CFD


 LONG


 400


 90.4896 USD




 CFD


 LONG


 3,700


 90.4896 USD




 CFD


 LONG


 400


 90.6450 USD




 CFD


 LONG


 712


 91.1150 USD




 CFD


 LONG


 17,816


 91.1150 USD




 CFD


 LONG


 2,000


 91.5222 USD




 CFD


 LONG


 2,400


 91.5620 USD




 CFD


 LONG


 62


 91.7500 USD




 CFD


 LONG


 25


 91.7500 USD




 CFD


 LONG


 2


 91.7500 USD




 CFD


 SHORT


 36


 89.0000 USD




 CFD


 SHORT


 64


 89.3400 USD




 CFD


 SHORT


 200


 89.6500 USD




 CFD


 SHORT


 3,000


 89.7306 USD




 CFD


 SHORT


 64


 89.7798 USD




 CFD


 SHORT


 800


 89.9730 USD




 CFD


 SHORT


 128


 91.6500 USD




 CFD


 SHORT


 1,222


 91.7500 USD




 CFD


 SHORT


 544


 91.7500 USD




 CFD


 SHORT


 86


 91.7500 USD




 CFD


 SHORT


 14


 91.7500 USD




 CFD


 SHORT


 2,098


 91.7500 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 05 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUVSRRRVUORAR